U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Visceral Crisis

MedGen UID:
1623170
•Concept ID:
C4527413
•
Disease or Syndrome

Definition

Severe organ dysfunction as assessed by signs, symptoms and laboratory studies, resulting from rapid progression of neoplastic disease. It is indicative of substantial visceral compromise and may serve as an indication for more aggressive therapeutic intervention. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVVisceral Crisis

Professional guidelines

PubMed

An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M, Schettini F, Rognoni C, Milani M, Jerusalem G, Bachelot T, De Laurentiis M, Thomas G, De Placido P, Arpino G, De Placido S, Cristofanilli M, Giordano A, Puglisi F, Pistilli B, Prat A, Del Mastro L, Venturini S, Generali D
Lancet Oncol 2019 Oct;20(10):1360-1369. Epub 2019 Sep 4 doi: 10.1016/S1470-2045(19)30420-6. PMID: 31494037

Recent clinical studies

Etiology

Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours.
Tay F, Buyukkor M, Duran AO
J Coll Physicians Surg Pak 2023 Aug;33(8):879-883. doi: 10.29271/jcpsp.2023.08.879. PMID: 37553926
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.
Funasaka C, Naito Y, Kusuhara S, Nakao T, Fukasawa Y, Mamishin K, Komuro A, Okunaka M, Kondoh C, Harano K, Kogawa T, Matsubara N, Hosono A, Kawasaki T, Mukohara T
Breast 2021 Aug;58:50-56. Epub 2021 Apr 10 doi: 10.1016/j.breast.2021.04.001. PMID: 33901922Free PMC Article
An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
The evolving management of metastatic triple negative breast cancer.
Malhotra MK, Emens LA
Semin Oncol 2020 Aug;47(4):229-237. Epub 2020 May 28 doi: 10.1053/j.seminoncol.2020.05.005. PMID: 32563561
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842

Diagnosis

Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours.
Tay F, Buyukkor M, Duran AO
J Coll Physicians Surg Pak 2023 Aug;33(8):879-883. doi: 10.29271/jcpsp.2023.08.879. PMID: 37553926
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature.
Targato G, Bortot L, Dri A, Bonotto M, Minisini AM, Fasola G, Mansutti M
Curr Oncol 2022 Dec 6;29(12):9630-9639. doi: 10.3390/curroncol29120756. PMID: 36547170Free PMC Article
An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842
Syphilitic meningomyelitis presenting with visceral crisis: A case report.
Sun L, Zheng N, Yang Y, Zhang HN
Medicine (Baltimore) 2018 Jul;97(30):e11661. doi: 10.1097/MD.0000000000011661. PMID: 30045319Free PMC Article

Therapy

Evaluating everolimus for the treatment of breast cancer.
Moreau-Bachelard C, Robert M, Gourmelon C, Bourbouloux E, Patsouris A, Frenel JS, Campone M
Expert Opin Pharmacother 2023 May-Aug;24(10):1105-1111. Epub 2023 May 18 doi: 10.1080/14656566.2023.2214677. PMID: 37183684
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.
Turner N, Dent RA, O'Shaughnessy J, Kim SB, Isakoff SJ, Barrios C, Saji S, Bondarenko I, Nowecki Z, Lian Q, Reilly SJ, Hinton H, Wongchenko MJ, Kovic B, Mani A, Oliveira M
Breast Cancer Res Treat 2022 Feb;191(3):565-576. Epub 2021 Dec 3 doi: 10.1007/s10549-021-06450-x. PMID: 34860318Free PMC Article
An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M, Schettini F, Rognoni C, Milani M, Jerusalem G, Bachelot T, De Laurentiis M, Thomas G, De Placido P, Arpino G, De Placido S, Cristofanilli M, Giordano A, Puglisi F, Pistilli B, Prat A, Del Mastro L, Venturini S, Generali D
Lancet Oncol 2019 Oct;20(10):1360-1369. Epub 2019 Sep 4 doi: 10.1016/S1470-2045(19)30420-6. PMID: 31494037

Prognosis

Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours.
Tay F, Buyukkor M, Duran AO
J Coll Physicians Surg Pak 2023 Aug;33(8):879-883. doi: 10.29271/jcpsp.2023.08.879. PMID: 37553926
An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
The evolving management of metastatic triple negative breast cancer.
Malhotra MK, Emens LA
Semin Oncol 2020 Aug;47(4):229-237. Epub 2020 May 28 doi: 10.1053/j.seminoncol.2020.05.005. PMID: 32563561
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
Barrios CH, Sampaio C, Vinholes J, Caponero R
Ann Oncol 2009 Jul;20(7):1157-62. Epub 2009 Feb 16 doi: 10.1093/annonc/mdn756. PMID: 19221149

Clinical prediction guides

Evaluating everolimus for the treatment of breast cancer.
Moreau-Bachelard C, Robert M, Gourmelon C, Bourbouloux E, Patsouris A, Frenel JS, Campone M
Expert Opin Pharmacother 2023 May-Aug;24(10):1105-1111. Epub 2023 May 18 doi: 10.1080/14656566.2023.2214677. PMID: 37183684
An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ, Tirona M
Med Oncol 2021 Mar 15;38(4):39. doi: 10.1007/s12032-021-01486-x. PMID: 33721121
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care.
Hui R, de Boer R, Lim E, Yeo B, Lynch J
Asia Pac J Clin Oncol 2021 Jan;17 Suppl 1:3-14. doi: 10.1111/ajco.13555. PMID: 33506626
The evolving management of metastatic triple negative breast cancer.
Malhotra MK, Emens LA
Semin Oncol 2020 Aug;47(4):229-237. Epub 2020 May 28 doi: 10.1053/j.seminoncol.2020.05.005. PMID: 32563561
Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842

Recent systematic reviews

Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH
J Clin Oncol 2020 Jun 1;38(16):1849-1863. Epub 2020 Feb 14 doi: 10.1200/JCO.19.03120. PMID: 32058842
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M, Schettini F, Rognoni C, Milani M, Jerusalem G, Bachelot T, De Laurentiis M, Thomas G, De Placido P, Arpino G, De Placido S, Cristofanilli M, Giordano A, Puglisi F, Pistilli B, Prat A, Del Mastro L, Venturini S, Generali D
Lancet Oncol 2019 Oct;20(10):1360-1369. Epub 2019 Sep 4 doi: 10.1016/S1470-2045(19)30420-6. PMID: 31494037

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...